Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population

Masayuki Hashiguchi, Takanori Tanaka, Mikiko Shimizu, Tomomi Tsuru, Takeshi Chiyoda, Kumika Miyawaki, Shin Irie, Osamu Takeuchi, Jun Hakamata, Mayumi Mochizuki

Research output: Contribution to journalArticle

Abstract

Sex differences in the prevalence of autoimmune diseases such as rheumatoid arthritis (RA) are well known, but little is known about those differences in relation to therapeutic response. Reduced folate carrier-1 (RFC-1), folypolyformyl glutamate synthase (FPGS), and γ-glutamyl hydrolase (GGH) are important transporters and enzymes that convert methotrexate (MTX) in the body. This study investigated the sex differences in mRNA expression of RFC-1, FPGS, and GGH in 190 unrelated healthy Japanese people. The genotypes and mRNA expression were determined using the real-time PCR method. Significant differences between men and women were observed in RFC-1, FPGS, and GGH mRNA expression. The mRNA expression of FPGS and GGH was greater in women than that in men, but the expression of RFC-1 was less in the former than the latter. In stratified analysis by genotype, significant differences in sex-specific mRNA expression were observed in G/G of FPGS, C/C of GGH 452, and C/C of GGH -401. All showed greater mRNA expression in women than in men. In the 5 single-nucleotide polymorphisms RFC-1 80G>A, RFC-1 -43T>C, FPGS 1994G>A, GGH 452C>T, and GGH -401C>T examined, the FPGS 1994 G/G (1.46-fold), GGH 452 C/C (2.16-fold), and GGH -401 C/C (2.68-fold) genotypes showed significantly higher mRNA expression in women than in men. Healthy Japanese adults in this study showed sex-specific differences in mRNA expression that differed among RFC-1, FPGS, and GGH. Therefore, the relationship between genetic polymorphisms and mRNA expression including sex differences might contribute to the variation in the efficacy/toxicity of MTX in patients with RA.

Original languageEnglish
JournalJournal of Clinical Pharmacology
DOIs
Publication statusAccepted/In press - 2016

Fingerprint

Reduced Folate Carrier Protein
Glutamate Synthase
Hydrolases
Sex Characteristics
Messenger RNA
Population
Genotype
Methotrexate
Rheumatoid Arthritis
Genetic Polymorphisms
Autoimmune Diseases
Single Nucleotide Polymorphism
Real-Time Polymerase Chain Reaction

Keywords

  • Folypolyformyl glutamate synthase
  • Genetic polymorphism
  • Healthy Japanese population
  • Methotrexate
  • MRNA expression
  • Reduced folate carrier-1
  • γ-glutamyl hydrolase

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population. / Hashiguchi, Masayuki; Tanaka, Takanori; Shimizu, Mikiko; Tsuru, Tomomi; Chiyoda, Takeshi; Miyawaki, Kumika; Irie, Shin; Takeuchi, Osamu; Hakamata, Jun; Mochizuki, Mayumi.

In: Journal of Clinical Pharmacology, 2016.

Research output: Contribution to journalArticle

Hashiguchi, Masayuki ; Tanaka, Takanori ; Shimizu, Mikiko ; Tsuru, Tomomi ; Chiyoda, Takeshi ; Miyawaki, Kumika ; Irie, Shin ; Takeuchi, Osamu ; Hakamata, Jun ; Mochizuki, Mayumi. / Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population. In: Journal of Clinical Pharmacology. 2016.
@article{f3c2331fc8ed4422ba171bcd481001da,
title = "Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population",
abstract = "Sex differences in the prevalence of autoimmune diseases such as rheumatoid arthritis (RA) are well known, but little is known about those differences in relation to therapeutic response. Reduced folate carrier-1 (RFC-1), folypolyformyl glutamate synthase (FPGS), and γ-glutamyl hydrolase (GGH) are important transporters and enzymes that convert methotrexate (MTX) in the body. This study investigated the sex differences in mRNA expression of RFC-1, FPGS, and GGH in 190 unrelated healthy Japanese people. The genotypes and mRNA expression were determined using the real-time PCR method. Significant differences between men and women were observed in RFC-1, FPGS, and GGH mRNA expression. The mRNA expression of FPGS and GGH was greater in women than that in men, but the expression of RFC-1 was less in the former than the latter. In stratified analysis by genotype, significant differences in sex-specific mRNA expression were observed in G/G of FPGS, C/C of GGH 452, and C/C of GGH -401. All showed greater mRNA expression in women than in men. In the 5 single-nucleotide polymorphisms RFC-1 80G>A, RFC-1 -43T>C, FPGS 1994G>A, GGH 452C>T, and GGH -401C>T examined, the FPGS 1994 G/G (1.46-fold), GGH 452 C/C (2.16-fold), and GGH -401 C/C (2.68-fold) genotypes showed significantly higher mRNA expression in women than in men. Healthy Japanese adults in this study showed sex-specific differences in mRNA expression that differed among RFC-1, FPGS, and GGH. Therefore, the relationship between genetic polymorphisms and mRNA expression including sex differences might contribute to the variation in the efficacy/toxicity of MTX in patients with RA.",
keywords = "Folypolyformyl glutamate synthase, Genetic polymorphism, Healthy Japanese population, Methotrexate, MRNA expression, Reduced folate carrier-1, γ-glutamyl hydrolase",
author = "Masayuki Hashiguchi and Takanori Tanaka and Mikiko Shimizu and Tomomi Tsuru and Takeshi Chiyoda and Kumika Miyawaki and Shin Irie and Osamu Takeuchi and Jun Hakamata and Mayumi Mochizuki",
year = "2016",
doi = "10.1002/jcph.760",
language = "English",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population

AU - Hashiguchi, Masayuki

AU - Tanaka, Takanori

AU - Shimizu, Mikiko

AU - Tsuru, Tomomi

AU - Chiyoda, Takeshi

AU - Miyawaki, Kumika

AU - Irie, Shin

AU - Takeuchi, Osamu

AU - Hakamata, Jun

AU - Mochizuki, Mayumi

PY - 2016

Y1 - 2016

N2 - Sex differences in the prevalence of autoimmune diseases such as rheumatoid arthritis (RA) are well known, but little is known about those differences in relation to therapeutic response. Reduced folate carrier-1 (RFC-1), folypolyformyl glutamate synthase (FPGS), and γ-glutamyl hydrolase (GGH) are important transporters and enzymes that convert methotrexate (MTX) in the body. This study investigated the sex differences in mRNA expression of RFC-1, FPGS, and GGH in 190 unrelated healthy Japanese people. The genotypes and mRNA expression were determined using the real-time PCR method. Significant differences between men and women were observed in RFC-1, FPGS, and GGH mRNA expression. The mRNA expression of FPGS and GGH was greater in women than that in men, but the expression of RFC-1 was less in the former than the latter. In stratified analysis by genotype, significant differences in sex-specific mRNA expression were observed in G/G of FPGS, C/C of GGH 452, and C/C of GGH -401. All showed greater mRNA expression in women than in men. In the 5 single-nucleotide polymorphisms RFC-1 80G>A, RFC-1 -43T>C, FPGS 1994G>A, GGH 452C>T, and GGH -401C>T examined, the FPGS 1994 G/G (1.46-fold), GGH 452 C/C (2.16-fold), and GGH -401 C/C (2.68-fold) genotypes showed significantly higher mRNA expression in women than in men. Healthy Japanese adults in this study showed sex-specific differences in mRNA expression that differed among RFC-1, FPGS, and GGH. Therefore, the relationship between genetic polymorphisms and mRNA expression including sex differences might contribute to the variation in the efficacy/toxicity of MTX in patients with RA.

AB - Sex differences in the prevalence of autoimmune diseases such as rheumatoid arthritis (RA) are well known, but little is known about those differences in relation to therapeutic response. Reduced folate carrier-1 (RFC-1), folypolyformyl glutamate synthase (FPGS), and γ-glutamyl hydrolase (GGH) are important transporters and enzymes that convert methotrexate (MTX) in the body. This study investigated the sex differences in mRNA expression of RFC-1, FPGS, and GGH in 190 unrelated healthy Japanese people. The genotypes and mRNA expression were determined using the real-time PCR method. Significant differences between men and women were observed in RFC-1, FPGS, and GGH mRNA expression. The mRNA expression of FPGS and GGH was greater in women than that in men, but the expression of RFC-1 was less in the former than the latter. In stratified analysis by genotype, significant differences in sex-specific mRNA expression were observed in G/G of FPGS, C/C of GGH 452, and C/C of GGH -401. All showed greater mRNA expression in women than in men. In the 5 single-nucleotide polymorphisms RFC-1 80G>A, RFC-1 -43T>C, FPGS 1994G>A, GGH 452C>T, and GGH -401C>T examined, the FPGS 1994 G/G (1.46-fold), GGH 452 C/C (2.16-fold), and GGH -401 C/C (2.68-fold) genotypes showed significantly higher mRNA expression in women than in men. Healthy Japanese adults in this study showed sex-specific differences in mRNA expression that differed among RFC-1, FPGS, and GGH. Therefore, the relationship between genetic polymorphisms and mRNA expression including sex differences might contribute to the variation in the efficacy/toxicity of MTX in patients with RA.

KW - Folypolyformyl glutamate synthase

KW - Genetic polymorphism

KW - Healthy Japanese population

KW - Methotrexate

KW - MRNA expression

KW - Reduced folate carrier-1

KW - γ-glutamyl hydrolase

UR - http://www.scopus.com/inward/record.url?scp=84970990796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970990796&partnerID=8YFLogxK

U2 - 10.1002/jcph.760

DO - 10.1002/jcph.760

M3 - Article

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

ER -